Clinical-stage company developing gene therapies for severe genetic and rare diseases.
Issues related to drug pricing including S. 2543 Prescription Drug pricing Act and issues related to value based payment over time; H.R. 5882 the GENE Therapy Payment Act; H.R. 3 Elijah E. Cummings lower drug costs act; issues related to Medicaid Best Price and AMP reporting. Issues related to H.R. 3935, the Protecting Patients Transportation to Care Act.
MMM - Medicare/Medicaid
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
EMILY PORTER STACEY HUGHES